Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2025-12-24 @ 11:50 AM
NCT ID:
NCT00240461
Eligibility Criteria:
Inclusion Criteria:
* Age 65 years of age and older
* current season influenza immunization
* available for follow-up visits
* willing and able to sign written informed consent
Exclusion Criteria:
* HIV infection
* malignancy (under active observation or treatment)
* unstable cardiovascular diseases
* renal abnormalities (serum creatine \>200umol/l)
* pulmonary disease (chronic bronchitis, emphysema, or asthma requiring treatment in the last 3 months with oral steroids - prednisone \>10mg/day, other chronic respiratory illness)
* acute or active chronic liver disease
* neurologic or psychiatric disease (progressive or currently under treatment
* active tuberculosis
* multiple sclerosis
* bleeding disorders
* planned surgery over the course of the trial
* on immunosuppressive therapy
* taking oral steroids at dose = to prednisone 10 mg/day or more
* taking phenelzine, pentobarbital, haloperidol, warfarin, heparin
* use of natural health products(except the study product and vitamins and minerals with a dose \<600 mg/day of vitamin E and containing no vitamin K) including echinacea or ginseng-containing products (tea, capsules, extracts, tablets)
* current alcohol/drug abuse
* major surgery in the past 6 months
* allergies to ginseng
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT00240461
Study Brief:
Protocol Section:
NCT00240461